← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Buck Institute For Research On Aging
Novato, CA
$318,658,202
Total funding
232
Grants
Funding over time
peak $31.2M · FY2006–25$50M$37.5M$25M$12.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$316,537,375 · 230
DOE$1,150,827 · 1
DOD$970,000 · 1
By mechanism
R01$150,994,214 · 77
P01$26,900,149 · 19
U01$16,916,111 · 5
RL1$14,459,614 · 7
R21$12,210,773 · 26
U54$12,040,749 · 8
Investigators at Buck Institute For Research On Aging
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
New mechanistic insights into how the gut metabolite urolithin A extends lifespan and prevents AD$3,414,407
RF1 · FY2018 · AG
A temporal bioenergetic, metabolomics, and proteomic map of Alzheimer's disease in invertebrate models$3,011,435
RF1 · FY2017 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,890,235
P01 · FY2021 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,884,435
P01 · FY2022 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,878,430
P01 · FY2023 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,872,219
P01 · FY2024 · AG
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$2,808,473
P01 · FY2025 · AG
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,700,000
U54 · FY2021 · AG
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,492,316
U54 · FY2022 · AG
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,390,550
U54 · FY2024 · AG
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,237,050
U54 · FY2023 · AG
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,220,833
U54 · FY2025 · AG
TAKEOFF: Targeting Aging with Ketone Ester in Older adults for Function in Frailty$2,039,697
RF1 · FY2025 · AG
Mitochondrial Dysfunction in Aging and Disease$1,920,859
P01 · FY2010 · AG
Cellular senescence and Alzheimer's disease$1,891,636
RF1 · FY2020 · AG
Mitochondrial Dysfunction in Aging and Disease$1,863,135
P01 · FY2011 · AG
timsTOF fleX MALDI-2 for Spatial Molecular Imaging$1,759,412
S10 · FY2025 · OD
Reversible Mitochondrial Protein Acetylation and Metabolic Regulation$1,603,291
R24 · FY2017 · DK
Mitochondrial Dysfunction in Aging and Disease$1,577,939
P01 · FY2009 · AG
DNA REPAIR, MUTATIONS AND CELLULAR AGING$1,546,401
P01 · FY2006 · AG